多腔分子描述器相互连接:用于预测血清白蛋白与药物结合的增强协议
Oluwole B Akawa1, Felix O Okunlola1, Mohammed Issa Alahmdi2
1Molecular Bio-computational and Drug Design Laboratory, School of Health Sciences, University of KwaZulu Natal, Westville Campus, Durban 4001, South Africa.
概括
预测人类血清白蛋白 (HSA) 上的药物结合部位对于药物发现至关重要. 这项研究将药物特性与HSA结合部位特征相关联,以提高预测准确度,以获得更好的药物设计.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 计算化学计算化学
背景情况:
- 人体血清白蛋白 (HSA) 对于药物运输至关重要,影响药物分布和新陈代谢.
- 准确预测HSA上的药物连接体结合点对于优化药物发现中的ADME特性至关重要.
- 现有的 in silico 工具在准确预测 HSA 结位点方面面临着挑战.
研究的目的:
- 开发一种可靠的方法来预测HSA-连接体结合位点.
- 建立药物的物理化学特性和HSA结合部位特征之间的相关性.
- 利用多腔分子描述器来提高结合部位的预测.
主要方法:
- 使用实验上可用的和结晶的HSA结合药物.
- 相关的分子描述符 (nHD,nHet,TPSA,MW,LogD) 与HSA结合部位特征 (疏水性,体积等) 相关联. ) 的情况.
- 采用多腔分子描述器进行深入分析.
主要成果:
- 确定了关键分子描述符 (nHD,TPSA,LogD,nHet,MW) 具有对HSA结合位点的高预测能力.
- 在药物物理化学性质和HSA结合部位架构之间建立了强烈的相关性.
- 证明了多腔描述符在预测结合地点方面的有效性.
结论:
- 开发的相关性为准确预测血清白蛋白结合部位提供了基础.
- 这种方法有助于合理的药物设计,改善药物输送,生物可用性和药理动力学.
- 这些发现为推进药物发现和开发过程提供了关键的见解.
相关概念视频
01:22Protein-Drug Binding: Determination Methods
210
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
210
01:29Drug Distribution: Plasma Protein Binding
5.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.7K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
167
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
167
01:16Protein-Drug Binding: Mechanism and Kinetics
528
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
528
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
47
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
47
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
116
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
116